NeoTherapeutics, Inc. is a development-stage biopharmaceutical company engaged in the discovery and development of novel therapeutic drugs intended to treat neurological diseases such as memory deficits associated with Alzheimer\'s disease and aging, spinal cord injuries,Parkinson\'s disease and other neurodegenerative and psychiatric diseases. The Company has also become engaged in research involving functional genomics and the development of oncology drugs.